2022
DOI: 10.3390/jpm12030485
|View full text |Cite
|
Sign up to set email alerts
|

Normal Lung Tissue CT Density Changes after Volumetric-Arc Radiotherapy (VMAT) for Lung Cancer

Abstract: Radiation-induced lung injury remains a significant toxicity in thoracic radiotherapy. Because a precise diagnosis is difficult and commonly used assessment scales are unclear and subjective, there is a need to establish quantitative and sensitive grading methods. The lung tissue density change expressed in Hounsfield units (HUs) derived from CT scans seems a useful numeric surrogate. The study aimed to confirm a dose-response effect on HU value changes (ΔHU), their evolution in time, and the impact of selecte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 32 publications
(45 reference statements)
1
0
0
Order By: Relevance
“…In the ABM-MC model the dose was delivered once at the beginning of the simulation and the parameters were set to the same values as those in the ABM model (notably: phagocytic fraction = 100%, phagocytic index = 1, apoptotic-tosenescent ratio = 0 and bystander threshold = 2). As can be seen from figure 3, both the early and the late components of the DECM (for the ABM-MC model) could be fitted by the equations ( 2) and (3) and are qualitatively in agreement with experimental data [18][19][20][21] . As expected, the DECM increases as a function of the dose and reaches a plateau around 20Gy for the early component and 30Gy for the late component.…”
Section: Simulation Outcomes: Abm-mc Vs Abmsupporting
confidence: 78%
“…In the ABM-MC model the dose was delivered once at the beginning of the simulation and the parameters were set to the same values as those in the ABM model (notably: phagocytic fraction = 100%, phagocytic index = 1, apoptotic-tosenescent ratio = 0 and bystander threshold = 2). As can be seen from figure 3, both the early and the late components of the DECM (for the ABM-MC model) could be fitted by the equations ( 2) and (3) and are qualitatively in agreement with experimental data [18][19][20][21] . As expected, the DECM increases as a function of the dose and reaches a plateau around 20Gy for the early component and 30Gy for the late component.…”
Section: Simulation Outcomes: Abm-mc Vs Abmsupporting
confidence: 78%